Nateglinide dispersible tablets
Function and Efficacy
Not yet clear.
Ingredients
Naglina
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| NateglinideIngredients |
Not yet clear More |
105816-04-4 | 24 |
Appearance
This product is white tablets.
Indication
This product can be used alone for patients with type 2 diabetes who cannot effectively control hyperglycemia through diet and exercise, or for patients with type 2 diabetes who cannot effectively control hyperglycemia with metformin. It is used in combination with metformin, but it cannot replace metformin. Nateglinide is not suitable for patients with type 2 diabetes who are not ideal for treatment with sulfonylurea hypoglycemic drugs.
Usage and Dosage
oral.
Adverse Reactions
Not yet clear.
Precautions
1. Contraindicated for patients who are allergic to the active ingredients or any excipients of the drug; 2. Contraindicated for patients with type 2 diabetes (insulin-dependent diabetes); 3. Contraindicated for patients with diabetic ketoacidosis; 4. Use with caution in children, the elderly, pregnant women and lactating women.
Special Population Medication
Precautions for children: Use with caution in children. Precautions for pregnancy and lactation: Precautions for pregnant and lactating women: Do not use in pregnant and lactating women. Precautions for the elderly: Use with caution in elderly patients.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Keep tightly closed.
Packaging Specification
60mg
Validity Period
24 months
Manufacturer
CSPC OUYI Pharmaceutical Co., Ltd.
-
Founded in:
2001-03-29 -
Address:
No. 88, Yangzi Road, Shijiazhuang Economic and Technological Development Zone -
Tax NO.:
91130100601289268L -
Registered Funds:
298 million yuan -
Website:
-
Email: